
Castlight Health, Inc. Income Statement 2020-2011 | CSLT
Brief overview of income trends at Castlight Health, Inc.
The figures are compared over a five-year interval. Castlight Health, Inc. reported revenue of $75.3 million in 2015 and $147 million by 2020. The five-year change reached +94.8%, while CAGR stood at 14.3%. The pace indicates confident and sustained business growth.
Gross profit was 41.5 million dollars at the start and 94.7 million dollars at the end of the period (+127.9%). Gross profit as a share of revenue changed from 55.2% to 64.5%. The expansion indicates stronger pricing power or better control of direct costs.
The operating result measured by EBITDA moved from −$78.2 million to −$5.9 million, or +92.4%. The operating result changed at a rate similar to sales. The EBITDA share of revenue changed from −103.8% to −4.1%. The business generated more EBITDA from each unit of revenue.
Comparing the endpoints shows a move from −79.9 million dollars to −62.2 million dollars. The loss narrowed, although sustainable profitability has not yet returned.
The market value of the business moved from 310 million dollars to 275 million dollars, or −11.2%. Lower capitalization reflects weaker investor expectations.
Financial takeaway
The results present an uneven picture without one dominant signal. The constructive conclusion rests on higher operating efficiency, a larger revenue base and net-income growth. Caution is warranted because of a low EBITDA margin. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Castlight Health, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
275 M | 184 M | 388 M | 433 M | 323 M | 310 M | 661 M | - | - | - |
Shares |
155 M | 145 M | 138 M | 126 M | 101 M | 93.8 M | 74.4 M | - | - | - |
Net Income |
-62.2 M | -40 M | -39.7 M | -55.6 M | -58.5 M | -79.9 M | -85.9 M | -62.2 M | -35 M | -19.9 M |
Revenue |
147 M | 143 M | 156 M | 131 M | 102 M | 75.3 M | 45.6 M | 13 M | 4.15 M | 1.88 M |
EBITDA |
-5.95 M | -35.4 M | -33 M | -54.8 M | -55.8 M | -78.2 M | -84.8 M | -61.7 M | -34.9 M | -19.9 M |
Operating Expenses |
107 M | 126 M | 136 M | 146 M | 126 M | 122 M | 104 M | 58 M | 30.8 M | 19.7 M |
General and Administrative Expenses |
25.7 M | 28 M | 25.6 M | 28.8 M | 26.9 M | 24.3 M | 19 M | 9.05 M | 5.21 M | 3.56 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Castlight Health, Inc. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Teladoc Health
TDOC
|
$ 6.26 | 0.24 % | $ 1.1 B | ||
|
10x Genomics
TXG
|
$ 65.6 | 4.71 % | $ 8.18 B | ||
|
Veeva Systems
VEEV
|
$ 264.84 | 1.3 % | $ 43.3 B | ||
|
Zhongchao
ZCMD
|
$ 0.85 | 0.29 % | $ 2.91 M | ||
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | ||
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | ||
|
R1 RCM
RCM
|
- | - | $ 3.81 B | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | ||
|
American Well Corporation
AMWL
|
$ 13.34 | 2.69 % | $ 214 M | ||
|
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | ||
|
Evolent Health
EVH
|
$ 4.22 | 1.41 % | $ 482 M | ||
|
GoodRx Holdings
GDRX
|
$ 3.52 | 1.15 % | $ 1.25 B | ||
|
Health Catalyst
HCAT
|
$ 1.7 | 0.59 % | $ 119 M | ||
|
HealthEquity
HQY
|
$ 93.36 | 0.24 % | $ 8.04 B | ||
|
HealthStream
HSTM
|
$ 28.72 | 1.78 % | $ 862 M | ||
|
So-Young International
SY
|
$ 2.65 | 0.18 % | $ 206 M | ||
|
iCAD
ICAD
|
- | - | $ 102 M | ||
|
Omnicell
OMCL
|
$ 33.88 | 0.32 % | $ 1.56 B | ||
|
OptimizeRx Corporation
OPRX
|
$ 7.6 | 1.74 % | $ 141 M | ||
|
Progyny
PGNY
|
$ 27.15 | 4.66 % | $ 2.31 B | ||
|
Phreesia
PHR
|
$ 10.22 | 0.76 % | $ 611 M | ||
|
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | ||
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | ||
|
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
- | - | $ 2.33 B | ||
|
Schrödinger
SDGR
|
$ 20.03 | 0.2 % | $ 1.47 B | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | ||
|
SCWorx Corp.
WORX
|
- | - | $ 7.71 M |